102 related articles for article (PubMed ID: 16772878)
1. A case of rhesus hemolytic disease with hemophagocytosis and severe iron overload due to multiple transfusions.
Yilmaz S; Duman N; Ozer E; Kavas N; Oren H; Demircioğlu F; Kumral A; Ozkan H; Irken G; Ozer E
J Pediatr Hematol Oncol; 2006 May; 28(5):290-2. PubMed ID: 16772878
[TBL] [Abstract][Full Text] [Related]
2. Severe iron overload and hyporegenerative anemia in a case with rhesus hemolytic disease: therapeutic approach to rare complications.
Demircioğlu F; Çağlayan Sözmen Ş; Yılmaz Ş; Ören H; Arslan N; Kumral A; Özer E; İrken G
Turk J Haematol; 2010 Sep; 27(3):204-8. PubMed ID: 27263607
[TBL] [Abstract][Full Text] [Related]
3. Chelation therapy for secondary neonatal iron over load: Lessons learned from rhesus hemolytic disease.
Khdair-Ahmad F; Aladily T; Khdair-Ahmad O; Badran EF
Turk J Pediatr; 2018; 60(3):335-339. PubMed ID: 30511551
[TBL] [Abstract][Full Text] [Related]
4. Successful chelation therapy in a case of neonatal iron overload following intravascular intrauterine transfusion.
Sreenan C; Idikio HA; Osiovich H
J Perinatol; 2000 Dec; 20(8 Pt 1):509-12. PubMed ID: 11190591
[TBL] [Abstract][Full Text] [Related]
5. Increased fetal iron load in rhesus hemolytic disease.
Aygun C; Tekinalp G; Gurgey A
Pediatr Hematol Oncol; 2004 Jun; 21(4):329-33. PubMed ID: 15205095
[TBL] [Abstract][Full Text] [Related]
6. Desferrioxamine treatment of iron overload secondary to RH isoimmunization and intrauterine transfusion in a newborn infant.
Yalaz M; Bilgin BS; Köroğlu OA; Ay Y; Arıkan C; Sagol S; Akısü M; Kültürsay N
Eur J Pediatr; 2011 Nov; 170(11):1457-60. PubMed ID: 21735053
[TBL] [Abstract][Full Text] [Related]
7. Understanding iron overload: screening, monitoring, and caring for patients with transfusion-dependent anemias.
Ault P; Jones K
Clin J Oncol Nurs; 2009 Oct; 13(5):511-7. PubMed ID: 19793708
[TBL] [Abstract][Full Text] [Related]
8. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
[TBL] [Abstract][Full Text] [Related]
9. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab.
Radhi M; Rumelhart S; Tatman D; Goldman F
J Pediatr Hematol Oncol; 2007 Feb; 29(2):125-7. PubMed ID: 17279011
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
Kalpatthi R; Peters B; Kane I; Holloman D; Rackoff E; Disco D; Jackson S; Laver JH; Abboud MR
Pediatr Blood Cancer; 2010 Dec; 55(7):1338-42. PubMed ID: 20981690
[TBL] [Abstract][Full Text] [Related]
11. [Secondary iron overload].
Galacteros F
Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():44-8. PubMed ID: 9827215
[No Abstract] [Full Text] [Related]
12. "Irony" of managing refractory anemia with transfusional support in hemophagocytic lymphohistiocytosis.
Lee S; Salehi I; Chary M; Schiano T; Mascarenhas JO
Transfus Apher Sci; 2016 Aug; 55(1):105-8. PubMed ID: 27102761
[TBL] [Abstract][Full Text] [Related]
13. Iron overload and toxicity: the hidden risk of multiple blood transfusions.
Shander A; Cappellini MD; Goodnough LT
Vox Sang; 2009 Oct; 97(3):185-97. PubMed ID: 19663936
[TBL] [Abstract][Full Text] [Related]
14. Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy.
Shander A; Sazama K
Transfusion; 2010 May; 50(5):1144-55. PubMed ID: 20088842
[TBL] [Abstract][Full Text] [Related]
15. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy-induced hemophagocytic lymphohistiocytosis combined with autoimmune hemolytic anemia.
Teng CL; Hwang GY; Lee BJ; Wang RC; Chou MM
J Chin Med Assoc; 2009 Mar; 72(3):156-9. PubMed ID: 19299225
[TBL] [Abstract][Full Text] [Related]
17. Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.
Delforge M; Selleslag D; Triffet A; Mineur P; Bries G; Graux C; Trullemans F; MacDonald K; Abraham I; Pluymers W; Ravoet C
Ann Hematol; 2011 Jun; 90(6):655-66. PubMed ID: 21318574
[TBL] [Abstract][Full Text] [Related]
18. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
[TBL] [Abstract][Full Text] [Related]
19. Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease.
Parekh C; Hofstra T; Church JA; Coates TD
Pediatr Blood Cancer; 2011 Mar; 56(3):460-2. PubMed ID: 21225928
[TBL] [Abstract][Full Text] [Related]
20. Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies.
Park IH; Kim Y; Kim JS; Cheong JW; Song JW; Min YH
Transfus Med; 2008 Apr; 18(2):97-103. PubMed ID: 18399843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
